AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2022
Jun 8, 2022
35221_dirs_2022-06-08_36db7c83-7d06-4450-8117-30a6bedfde19.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2022-05-31
Reporting Person: Gordon Michael Adam (General Counsel)
More from PAVmed Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Jan 23